AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
It is suggested that treatment-emergent skin toxic effects may serve as an early clinical marker of treatment benefit in patients receiving first-line enfortumab vedotin plus pembrolizumab and warrant prospective validation.
OBJECTIVE To evaluate the frequency at which patient-reported outcomes (PROs) are incorporated as nonmuscle-invasive bladder cancer (NMIBC) clinical trial endpoints. PATIENTS AND METHODS Interventional trials limited to patients with NMIBC were queried from clinicaltrials.gov from 1994 to 2025 (start of trial). Obser...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.